PD-L1, KIM-1 Levels May Predict Kidney Cancer Response to Opdivo, Yervoy
PD-L1 expression levels were found to predict improved outcomes with Opdivo and Yervoy in patients with ccRCC, while high KIM-1 ...
Tag: opdivo
FDA Approves Presurgical, Postsurgical Opdivo for NSCLC
The FDA has approved Opdivo as a presurgical and postsurgical treatment for some patients with non-small cell lung cancer. The ...
Opdivo Before and After Surgery Lowers Risk of Recurrence or Death by 40% in NSCLC
Opdivo Before and After Surgery Lowers Risk of Recurrence or Death by 40% in NSCLCFor patients with resectable (removable by ...
Pre- and Postsurgical Opdivo Does Not Boost Relapse-Free Survival in Kidney Cancer
The recurrence-free survival was 33% in the Opdivo group and surgery-only group in certain patients with kidney cancer. Adding Opdivo ...